Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya. - Wikidata - wikimedia - TriplyDB

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya.

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya.

http://www.wikidata.org/entity/Q35148486

about

Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.Cryptococcal Meningitis: Diagnosis and Management Update.New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.Cryptococcus and cryptococcosis in Cuba. A minireview.Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin.Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients.

P2860

Q34549620-AC4E0151-B3CE-468E-AEBB-C39A78CA91AC Q35951094-CC6C2B14-407E-4796-A318-DA67E05C144E Q38024052-E7199BD1-5BB5-42C8-9728-37CF686797B1 Q38270904-D1D920A3-50C5-48DE-B22C-017081E04742 Q38601382-DD06F55D-9EE0-4573-93BE-79632D04BB0B Q38851467-B8DE2D9A-35E9-489E-A30C-D51CD3BEE91C Q38916441-0360AA0E-CE94-4644-91CC-C37AA4D27AB9 Q40598601-2C17C52E-3BE1-496B-B9B8-457DC2B9EB94

P2860

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya.

http://www.wikidata.org/entity/Q35148486

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antifungal susceptibilities of ...... s from AIDS patients in Kenya.

@ast

Antifungal susceptibilities of ...... s from AIDS patients in Kenya.

@en

type

label

Antifungal susceptibilities of ...... s from AIDS patients in Kenya.

@ast

Antifungal susceptibilities of ...... s from AIDS patients in Kenya.

@en

prefLabel

Antifungal susceptibilities of ...... s from AIDS patients in Kenya.

@ast

Antifungal susceptibilities of ...... s from AIDS patients in Kenya.

@en

P1433

Q35148486-4D57631C-212B-4B50-896D-0A68C2FD9120

P1476

Q35148486-881246F7-5DAC-449A-B250-C3A513745350

P2093

Q35148486-130E7CD5-44CC-447C-B863-2996F62D130A

Q35148486-15992D8B-CA3F-4CC6-8043-F2271955D1B7

Q35148486-1BE2455D-8FB4-47CD-989A-7EE0F8B972DD

Q35148486-A86894FD-9F26-49E3-B45B-912CD7CD863F

Q35148486-B6F4AA68-E584-42CB-9ED0-9CB0151CAAE9

Q35148486-BB161B4C-1DF6-4F65-A792-AFDC14A2079D

Q35148486-C88F4A68-97FC-4C88-B1F7-99BE3C428C6B

Q35148486-EA11AE95-CC94-4DF0-944A-C9E322178E0C

P2860

Q35148486-068CF9EE-C0E6-41B1-82D6-C6C558513C70

Q35148486-0979243D-D146-445A-B3D8-AFA779038B4B

Q35148486-2B17CBE6-76CE-4F7B-84AC-AFF84B399119

Q35148486-2E36DED9-C5EE-45B8-903D-842F078239C9

Q35148486-314A0FE6-FE56-4C03-AAE4-C44E748DC2B8

Q35148486-3884FAA5-0E89-42A2-BB49-6D2D6355285A

Q35148486-6C214F45-0E7A-4464-858B-45B7C37B8EE8

Q35148486-7D879FBB-318F-4045-81FB-0D0E989AD09A

Q35148486-8373F5E5-1796-4506-B5BF-DDEAE25A829B

Q35148486-8A6260B6-B534-4C8E-B3D2-601F33B5A453

P304

Q35148486-CFD82519-ED22-4C9B-B1A0-3DE60D6B8C0E

P31

Q35148486-A56CB833-4624-4E7D-BE7F-0185D37A5513

P356

Q35148486-D4A0BA53-05D6-4BB0-84F9-58BFC705C58E

P433

Q35148486-268D83B3-DE74-46A5-ACDD-805D960E8FE9

P478

Q35148486-FF301452-19C4-4BC7-87BF-33E7E381FDD5

P50

Q35148486-256571E1-9F3B-4A6A-B9D2-AC8F4DF97902

P577

Q35148486-A0455FA2-D104-42F7-AF6B-AB541907316E

P5875

Q35148486-3DD88A2D-5159-468B-9F8A-800CBB605C99

P698

Q35148486-DFF120EB-9C0D-41C6-B91F-7C20000FF26C

P921

Q35148486-A90065F3-4343-4810-9E22-2F70769F23FC

Q35148486-B164551D-5601-4D66-BAC5-392A6165F277

P932

Q35148486-9253A9CD-2090-42A8-9AC7-6A0F9C11724C

P356

J.1439-0507.2010.01946.X

P1433

P1476

Antifungal susceptibilities of ...... s from AIDS patients in Kenya.

@en

P2093

Inmaculada Aban

http://www.w3.org/2001/XMLSchema#string

John Baddley

http://www.w3.org/2001/XMLSchema#string

Mirjam-Colette Kempf

http://www.w3.org/2001/XMLSchema#string

Pauline Jolly

http://www.w3.org/2001/XMLSchema#string

Peter Pappas

http://www.w3.org/2001/XMLSchema#string

Rennatus Mdodo

http://www.w3.org/2001/XMLSchema#string

Stephen A Moser

http://www.w3.org/2001/XMLSchema#string

Susan Odera

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).

Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.

Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.

Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.

Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.

P304

e438-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1439-0507.2010.01946.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51091514

http://www.w3.org/2001/XMLSchema#string

P698

21535451

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

3150616

http://www.w3.org/2001/XMLSchema#string